Biovail appoints new Vice President, Finance and Chief Financial Officer; Mahmood Khan Promoted to Chief Operating Officer.TORONTO, Canada--(BUSINESS WIRE)--January 10, 1996--Biovail Corporation International (AMEX AMEX See: American Stock Exchange , TSE See Tokyo Stock Exchange. TSE 1. See Tokyo Stock Exchange (TSE). 2. See Toronto Stock Exchange (TSE). :BVF BVF Biovail Corporation (stock symbol) BVF Berufsverband der Frauenärzte eV (Muenchen, Germany) BVF Bearing Versus Frequency ) today announced the appointment of Robert A. Podruzny as Vice President, Finance and Chief Financial Officer. Mahmood Khan, previous Chief Financial Officer, has been promoted to Chief Operating Officer Chief Operating Officer (COO) The officer of a firm responsible for day-to-day management, usually the president or an executive vice-president. . Prior to joining Biovail, Robert Podruzny was the Vice President and Chief Financial Officer of Browning-Ferris Industries, Ltd., a multi-national environmental service and waste management organization. Previously, he served as General Manager of the Health Promotion Division of MDS MDS, n See temporomandibular pain-dysfunction syndrome. MDS 1 Maternal deprivation syndrome, see there 2 Myelodysplastic syndrome, see there Health Group Limited, as well as Director of Finance of its Corporate Ventures Division. Mahmood Khan has served as Biovail's Chief Financial Officer for the past eight years. "We recognize the value and significant contributions Mahmood has made during his tenure as Chief Financial Officer and his appointment to Chief Operating Officer will clearly play an integral role in Biovail's future," commented Eugene Melnyk, Chairman of the Board of Biovail. With the appointment of Robert Podruzny to Vice President, Finance and Chief Financial Officer, Mr. Melnyk continued, "Robert comes to Biovail with a wealth of experience from both financial and executive positions within the healthcare industry. His experience spans the key areas of business planning, financial systems, acquisition strategies, and valuation. I am confident that both of these appointments will facilitate the productivity of the Company and enhance the strategic growth and development on an ongoing basis." Biovail Corporation International is an international full-service pharmaceutical company, engaged in the formulation, clinical evaluation clinical evaluation Medtalk An evaluation of whether a Pt has symptoms of a disease, is responding to treatment, or is having adverse reactions to therapy , registration and manufacture of drug products utilizing advanced drug delivery technologies. CONTACT: Biovail Corporation International Eugene Melnyk, 416/285-6000 or Morgen-Walke Associates Investor Relations Investor relations The process by which the corporation communicates with its investors. : Donna Stein Courtney Levi Press: Stacy Berns, 212/850-5600 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion